Debt-to-equity of Avidity Biosciences, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Avidity Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Avidity Biosciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 14%, a 29% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Avidity Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 14% +3% +29% 31 Dec 2025
Q3 2025 12% -0.74% -5.8% 30 Sep 2025
Q2 2025 11% -3.3% -24% 30 Jun 2025
Q1 2025 9.7% -5% -34% 31 Mar 2025
Q4 2024 11% -3.1% -23% 31 Dec 2024
Q3 2024 13% +2.6% +25% 30 Sep 2024
Q2 2024 14% +3.4% +32% 30 Jun 2024
Q1 2024 15% +3.3% +29% 31 Mar 2024
Q4 2023 14% +1.5% +12% 31 Dec 2023
Q3 2023 10% -2.6% -21% 30 Sep 2023
Q2 2023 11% -0.42% -3.8% 30 Jun 2023
Q1 2023 11% +0.93% +8.9% 31 Mar 2023
Q4 2022 12% +2.2% +22% 31 Dec 2022
Q3 2022 13% +3.6% +40% 30 Sep 2022
Q2 2022 11% +1.9% +20% 30 Jun 2022
Q1 2022 10% +1.9% +22% 31 Mar 2022
Q4 2021 9.9% 31 Dec 2021
Q3 2021 9.1% 30 Sep 2021
Q2 2021 9.2% 30 Jun 2021
Q1 2021 8.6% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.